Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001646:Bile / Q000032:analysis*; D001663:Bilirubin / Q000097:blood; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D002784:Cholesterol / Q000032:analysis*; D004796:Clinical Enzyme Tests; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004386:Duodenum; D005260:Female; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D008099:Liver / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D005723:gamma-Glutamyltransferase / Q000097:blood
D002635:Chenodeoxycholic Acid; D002784:Cholesterol; D007521:Isocitrate Dehydrogenase; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin